PEG-functionalized iron oxide nanoclusters loaded with chlorin e6 for targeted, NIR light induced, photodynamic therapy

Biomaterials

Volumn 34, Issue 36, 2013, Pages 9160-9170

  Li, Zhiwei ^a   Wang, Chao ^a   Cheng, Liang ^a   Gong, Hua ^a   Yin, Shengnan ^b   Gong, Qiufang ^a   Li, Yonggang ^b   Liu, Zhuang ^a  

^a SOOCHOW UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

Author keywords

Iron oxide nanoclusters; Magnetic resonance imaging; Magnetic tumor targeting; Near infrared; Photodynamic therapy

Indexed keywords

MAGNETIC TUMOR TARGETING; MULTIFUNCTIONAL AGENTS; NEAR INFRARED; PHOTODYNAMIC TREATMENTS; POLYETHYLENE GLYCOL (PEG); THERAPEUTIC EFFICACY; TISSUE PENETRATIONS; TREATMENT EFFICIENCY;

BIODEGRADATION; DISEASES; EXPERIMENTS; INFRARED DEVICES; MAGNETIC FIELDS; MAGNETIC RESONANCE IMAGING; NANOCLUSTERS; PHOTODYNAMIC THERAPY; TUMORS;

IRON OXIDES;

CHLORIN E6; IRON OXIDE; MACROGOL; NANOMATERIAL; PHOTOSENSITIZING AGENT; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIODEGRADABILITY; CANCER CELL; CANCER THERAPY; CONTROLLED STUDY; DRUG TARGETING; IN VITRO STUDY; IN VIVO STUDY; INFRARED RADIATION; LIGHT EXPOSURE; MAGNETIC FIELD; MAGNETISM; MOLECULE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; TUMOR GROWTH;

ANIMALIA;

IRON OXIDE NANOCLUSTERS; MAGNETIC RESONANCE IMAGING; MAGNETIC TUMOR TARGETING; NEAR-INFRARED; PHOTODYNAMIC THERAPY;

ANIMALS; CELL LINE, TUMOR; CELL SURVIVAL; ENDOCYTOSIS; FERRIC COMPOUNDS; HUMANS; INFRARED RAYS; MICE; MICE, INBRED BALB C; NANOPARTICLES; NIH 3T3 CELLS; PHOTOCHEMOTHERAPY; POLYETHYLENE GLYCOLS; PORPHYRINS;

EID: 84883748340     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.08.041     Document Type: Article

References (44)

1. Celli J.P., Spring B.Q., Rizvi I., Evans C.L., Samkoe K.S., Verma S., et al. Imaging and photodynamic therapy: mechanisms, monitoring, and optimization. Chem Rev 2010, 110:2795-2838.
2. Liu X., Tao H., Yang K., Zhang S., Lee S.-T., Liu Z. Optimization of surface chemistry on single-walled carbon nanotubes for invivo photothermal ablation of tumors. Biomaterials 2011, 32:144-151.
3. Yang K., Hu L., Ma X., Ye S., Cheng L., Shi X., et al. Multimodal imaging guided photothermal therapy using functionalized graphene nanosheets anchored with magnetic nanoparticles. Adv Mater 2012, 24:1868-1872.
4. Cheng L., Yang K., Chen Q., Liu Z. Organic stealth nanoparticles for highly effective invivo near-infrared photothermal therapy of cancer. ACS Nano 2012, 6:5605-5613.
5. Yang K., Zhang S., Zhang G., Sun X., Lee S.-T., Liu Z. Graphene in mice: ultrahigh invivo tumor uptake and efficient photothermal therapy. Nano Lett 2010, 10:3318-3323.
6. von Maltzahn G., Park J.-H., Agrawal A., Bandaru N.K., Das S.K., Sailor M.J., et al. Computationally guided photothermal tumor therapy using long-circulating gold nanorod antennas. Cancer Res 2009, 69:3892-3900.
7. Huang P., Lin J., Wang X., Wang Z., Zhang C., He M., et al. Light-triggered theranostics based on photosensitizer-conjugated carbon dots for simultaneous enhanced-fluorescence imaging and photodynamic therapy. Adv Mater 2012, 24:5104-5110.
8. Ng K.K., Lovell J.F., Vedadi A., Hajian T., Zheng G. Self-assembled porphyrin nanodiscs with structure-dependent activation for phototherapy and photodiagnostic applications. ACS Nano 2013, 7:3484-3490.
9. Jang B., Park J.-Y., Tung C.-H., Kim I.-H., Choi Y. Gold nanorod-photosensitizer complex for near-infrared fluorescence imaging and photodynamic/photothermal therapy invivo. ACS Nano 2011, 5:1086-1094.
10. Wang J., Zhu G., You M., Song E., Shukoor M.I., Zhang K., et al. Assembly of aptamer switch probes and photosensitizer on gold nanorods for targeted photothermal and photodynamic cancer therapy. ACS Nano 2012, 6:5070-5077.
11. Dolmans D.E.J.G.J., Fukumura D., Jain R.K. Photodynamic therapy for cancer. Nat Rev Cancer 2003, 3:380-387.
12. Cheng Y., Meyers J.D., Broome A.-M., Kenney M.E., Basilion J.P., Burda C. Deep penetration of a PDT drug into tumors by noncovalent drug-gold nanoparticle conjugates. JAm Chem Soc 2011, 133:2583-2591.
13. Maeda H. The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting. Adv Enzyme Regul 2001, 41:189-207.
14. Maeda H. Tumor-selective delivery of macromolecular drugs via the EPR effect: background and future prospects. Bioconjug Chem 2010, 21:797-802.
15. Fang J., Nakamura H., Maeda H. The EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. Adv Drug Deliv Rev 2011, 63:136-151.
16. Cheng L., Yang K., Li Y., Zeng X., Shao M., Lee S.T., et al. Multifunctional nanoparticles for upconversion luminescence/MR multimodal imaging and magnetically targeted photothermal therapy. Biomaterials 2012, 33:2215-2222.
17. Mikhaylov G., Mikac U., Magaeva A.A., Itin V.I., Naiden E.P., Psakhye I., et al. Ferri-liposomes as an MRI-visible drug-delivery system for targeting tumours and their microenvironment. Nat Nanotechnol 2011, 6:594-602.
18. Alexiou C., Jurgons R., Seliger C., Brunke O., Iro H., Odenbach S. Delivery of superparamagnetic nanoparticles for local chemotherapy after intraarterial infusion and magnetic drug targeting. Anticancer Res 2007, 27:2019-2022.
19. Polyak B., Friedman G. Magnetic targeting for site-specific drug delivery: applications and clinical potential. Expert Opin Drug Deliv 2009, 6:53-70.
20. Chertok B., Moffat B.A., David A.E., Yu F., Bergemann C., Ross B.D., et al. Iron oxide nanoparticles as a drug delivery vehicle for MRI monitored magnetic targeting of brain tumors. Biomaterials 2008, 29:487-496.
21. Goodwin S., Peterson C., Hoh C., Bittner C. Targeting and retention of magnetic targeted carriers (MTCs) enhancing intra-arterial chemotherapy. JMagn Magn Mater 1999, 194:132-139.
22. Alexiou C., Arnold W., Klein R.J., Parak F.G., Hulin P., Bergemann C., et al. Locoregional cancer treatment with magnetic drug targeting. Cancer Res 2000, 60:6641-6648.
23. Babincová M., Babinec P., Bergemann C. High-gradient magnetic capture of ferrofluids: implications for drug targeting and tumor embolization. JBiosci 2001, 56:909-911.
24. Alexiou C., Arnold W., Hulin P., Klein R.J., Renz H., Parak F.G., et al. Magnetic mitoxantrone nanoparticle detection by histology, X-ray and MRI after magnetic tumor targeting. JMagn Magn Mater 2001, 225:187-193.
25. Zhang F., Braun G.B., Pallaoro A., Zhang Y., Shi Y., Cui D., et al. Mesoporous multifunctional upconversion luminescent and magnetic "nanorattle" materials for targeted chemotherapy. Nano Lett 2011, 12:61-67.
26. Sun Y., Chen Z.-L., Yang X.-X., Huang P., Zhou X.-P., Du X.-X. Magnetic chitosan nanoparticles as a drug delivery system for targeting photodynamic therapy. Nanotechnology 2009, 20:135102.
27. Huang P., Li Z., Lin J., Yang D., Gao G., Xu C., et al. Photosensitizer-conjugated magnetic nanoparticles for invivo simultaneous magnetofluorescent imaging and targeting therapy. Biomaterials 2011, 32:3447-3458.
28. Xuan S., Wang F., Wang Y.-X.J., Jimmy C.Y., Leung K.C.-F. Facile synthesis of size-controllable monodispersed ferrite nanospheres. JMater Chem 2010, 20:5086-5094.
29. Cheng L., Yang K., Li Y., Chen J., Wang C., Shao M., et al. Facile preparation of multifunctional upconversion nanoprobes for multimodal imaging and dual-targeted photothermal therapy. Angew Chem Int Ed 2011, 123:7523-7528.
30. Amstad E., Gillich T., Bilecka I., Textor M., Reimhult E. Ultrastable iron oxide nanoparticle colloidal suspensions using dispersants with catechol-derived anchor groups. Nano Lett 2009, 9:4042-4048.
31. Ling D., Hyeon T. Chemical design of biocompatible iron oxide nanoparticles for medical applications. Small 2013, 9:1450-1466.
32. ®. JExp Bot 2006, 57:1725-1734.
33. Shultz M.D., Reveles J.U., Khanna S.N., Carpenter E.E. Reactive nature of dopamine as a surface functionalization agent in iron oxide nanoparticles. JAm Chem Soc 2007, 129:2482-2487.
34. Wang L., Yang Z., Gao J., Xu K., Gu H., Zhang B., et al. Abiocompatible method of decorporation: bisphosphonate-modified magnetite nanoparticles to remove uranyl ions from blood. JAm Chem Soc 2006, 128:13358-13359.
35. Downing H.D., Williams D. Optical constants of water in the infrared. JGeophys Res 1975, 80:1656-1661.
36. Hale G.M., Querry M.R. Optical constants of water in the 200-nm to 200-μm wavelength region. Appl Opt 1973, 12:555-563.
37. Hassan M., Klaunberg B.A. Biomedical applications of fluorescence imaging invivo. Comp Med 2004, 54:635-644.
38. Zhu Z., Tang Z., Phillips J.A., Yang R., Wang H., Tan W. Regulation of singlet oxygen generation using single-walled carbon nanotubes. JAm Chem Soc 2008, 130:10856-10857.
39. Xie J., Huang J., Li X., Sun S., Chen X. Iron oxide nanoparticle platform for biomedical applications. Curr Med Chem 2009, 16:1278-1294.
40. Tian B., Wang C., Zhang S., Feng L., Liu Z. Photothermally enhanced photodynamic therapy delivered by nano-graphene oxide. ACS Nano 2011, 5:7000-7009.
41. Neuberger T., Schöpf B., Hofmann H., Hofmann M., Von Rechenberg B. Superparamagnetic nanoparticles for biomedical applications: possibilities and limitations of a new drug delivery system. JMagn Magn Mater 2005, 293:483-496.
42. Arruebo M., Fernández-Pacheco R., Ibarra M.R., Santamaría J. Magnetic nanoparticles for drug delivery. Nano Today 2007, 2:22-32.
43. Vonarbourg A., Passirani C., Saulnier P., Benoit J.-P. Parameters influencing the stealthiness of colloidal drug delivery systems. Biomaterials 2006, 27:4356-4373.
44. Lee N., Hyeon T. Designed synthesis of uniformly sized iron oxide nanoparticles for efficient magnetic resonance imaging contrast agents. Chem Soc Rev 2012, 41:2575-2589.